Cognitive Training for Serious Mental Illness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new therapy called Targeted Cognitive Training (TCT) for Veterans with serious mental illnesses such as schizophrenia, bipolar disorder, or PTSD. The goal is to improve sensory information processing, enhancing overall mental and social functioning. Participants will receive either TCT alongside their usual care or just their usual care for comparison. Veterans currently receiving treatment at VA Psychosocial Rehabilitation and Recovery Centers, who experience cognitive challenges due to their mental health condition, might be a good fit.
As an unphased trial, this study offers Veterans the opportunity to potentially benefit from innovative therapy while contributing to valuable research.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that Targeted Cognitive Training is safe for Veterans with serious mental illnesses?
Research shows that Targeted Cognitive Training (TCT) may benefit individuals with severe mental illness. Although specific safety data for TCT is unavailable, similar cognitive training types have been studied. These studies indicate that such methods can improve thinking skills without causing serious side effects. Generally, participants tolerate these exercises well.
The trial phase is marked as "Not Applicable," indicating that TCT is neither a new drug nor an invasive treatment. It likely resembles therapies safely used in other contexts, suggesting a lower risk of side effects. However, participants should discuss any concerns with the trial team before joining.12345Why are researchers excited about this trial?
Researchers are excited about Targeted Cognitive Training (TCT) for serious mental illness because it offers a fresh approach to enhancing cognitive functions, which traditional medications like antipsychotics or mood stabilizers don't specifically address. Unlike standard treatments that primarily focus on managing symptoms, TCT aims to improve mental processes such as memory, attention, and problem-solving skills through structured exercises. This method could potentially lead to better overall functioning and quality of life for individuals with serious mental illnesses, providing benefits beyond symptom control.
What evidence suggests that Targeted Cognitive Training is effective for serious mental illness?
Research has shown that Targeted Cognitive Training (TCT) can enhance brain function in individuals with serious mental health issues. This training includes exercises that become more challenging as participants improve, aiding memory and thinking skills. One study found that these improvements in cognitive and daily activities persisted for six months after the training concluded. Approximately 67% of studies reported significant improvements in at least one area of cognitive skills. In this trial, participants will either receive TCT in addition to their Treatment as Usual (TAU) or continue with their standard TAU program. This indicates that TCT can be a promising method to enhance mental processing and overall quality of life for those with serious mental health conditions.36789
Who Is on the Research Team?
Gregory Light, PhD
Principal Investigator
VA San Diego Healthcare System, San Diego, CA
Are You a Good Fit for This Trial?
This trial is for Veterans with serious mental illnesses like schizophrenia, bipolar disorder, psychosis, or PTSD who are receiving care in VA Psychosocial Rehabilitation and Recovery Centers. It's designed to help those struggling with cognitive impairments due to their conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Enrolled patients complete clinical, cognitive and functional measures and candidate EEG biomarkers at baseline
Treatment
Participants receive 30 hours of Targeted Cognitive Training (TCT) in addition to Treatment as Usual (TAU)
Follow-up
Repeat assessment occurs after TCT session #10, 20, and 30, and again 12 weeks after the cessation of TCT to evaluate the durability of observed gains
What Are the Treatments Tested in This Trial?
Interventions
- Targeted Cognitive Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
University of California, San Diego
Collaborator